NLRP3-IN-17 is a potent, selective, and orally active inhibitor of the NLRP3 inflammasome, demonstrating an IC50 of 7 nM. It effectively inhibits NLRP3-dependent IL-1beta secretion in mice, making it a valuable compound for research into chronic inflammatory diseases (1).